Stay updated on Pembrolizumab for Leptomeningeal Disease Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Leptomeningeal Disease Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:27:32.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-25T02:35:30.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now shows revision v3.7.2 instead of v3.7.1. The study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T02:23:27.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T03:21:33.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A 403 Forbidden error page now appears for the study record, showing a minimal header, a 403 message, and a Home button. The updates include the HTML boilerplate and a site revision note.
    Difference
    18%
    Check dated 2026-09-20T01:15:03.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision changed from v3.6.5 to v3.6.6, indicating a small update to the page’s revision/versioning. The visible content and user experience remain unaffected.
    Difference
    0.1%
    Check dated 2026-08-29T21:54:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Leptomeningeal Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leptomeningeal Disease Clinical Trial page.